Following its characterization in diverse carcinomas and leukemia, our study therefore recommends further investigation of RON as a molecular component in the progression of sarcomas, possibly with a more prominent role in metastasis than in proliferation of established tumors or as an oncogenic driver-RTK. Here, MST1R is linked to carcinoma.